Author Guidelines

Editorial Policies and Scope:

The Nigerian Journal of Pharmacy (ISSN 0331 670X) is published a minimum of twice a year. It is a peer reviewed journal designed to meet the continuing educational needs of pharmacists and related discipline in Nigeria, Africa and the international medical communities.

The Nigerian Journal of Pharmacy is a publication of the Pharmaceutical Society of Nigeria. The Nigerian Journal of Pharmacy considers all manuscripts on the condition that they have not been previously published, nor are they submitted for consideration for publication or in press elsewhere. Nigerian Journal of Pharmacy publishes original research papers, critical reviews, systematic reviews personal views and short communications in the following areas: Pharmaceutics and Pharmaceutical Technology, Pharmacology and Toxicology, Pharmaceutical/ Medicinal Chemistry and Analysis, Pharmacognosy, and Pharmaceutical Microbiology, Clinical Pharmacy, Pharmaceutical Care, Medicines Management, Pharmacoeconomics, Industrial Pharmacy, Social and Administrative Pharmacy, Biomedical and other related disciplines.


To promote pharmacy practice research for the advancement of pharmacy profession.

To enhance the competencies of practicing pharmacists.

To provide an international forum for the communication and evaluation of data, methods and opinions in pharmacy practice and related disciplines.

The financial implication per scientific publication is as follows:

  1. As a member of PSN You will be paying N25,000 only– attach proof of payment of 2021 PSN National Capitation, and Current License.
  2. For members not currently registered in this financial year (and non-pharmacists), payment is N45,000 only.
  3. International authors are to pay $150


Payment to: 1012355551 / Pharmaceutical Society of Nigeria / Zenith Bank 

Kindly send the proof of payment to this email for confirmation.

Manuscript Submission

The complete manuscript should be sent as an e-mail attachment to:

 or  with the journal name and “Article Submission” in the subject line. A cover letter should accompany the submission and should be addressed to:

The Editor-in-Chief

Nigerian Journal of Pharmacy

Pharmacy House, 32, Faramobi Ajike, Street,

Anthony Village, Lagos, Nigeria

P.O Box 531, Mushin Lagos, Nigeria




Phone: +2348036985621

Manuscript Preparation

Review Article:  Maximum length of manuscripts should be 6000 words (24 pages, double-spaced)

Research Article: 5000 words (18 pages, double-spaced)

Technical notes, Commentaries and Short communications (Cameo): 1,500 (6 pages, double-spaced)

For other types of presentations, e.g. letters to the Editor, contact the Editor-in-Chief

 Manuscript Format

The preferred format of all manuscripts is MS Word (Font type: Times New Roman, Font size: 12). Illustrations (figures) and images must be inserted in the manuscript at the position they should appear when published.

 Manuscript Style

Manuscript should be written in English

Each manuscript should be typed double-spaced on A4 (8.5″ × 11″) paper size with 1 inch margins. It should be arranged in the following order:  Title, Abstract, Keywords (3 to 5), Introduction, Materials and Methods (Methods for Operational Research), Results, Discussion, Conclusion, Acknowledgment, and References.

First page of manuscript

This should include the title of the article, authors’ names (First name, middle initial and then the last name of each author) and their affiliations. The corresponding author must provide the full corresponding address (including telephone and e-mail address) at the bottom of the page.

Second page of manuscript

The Abstract (no more than 350 words) should be presented in the second page along with title and keywords (4 to 6). The abstract should be structured into: Background, Methods, Results, and Conclusion.


An introduction should provide a background to the study (appropriate for an international audience). Related literature based on the objectives of the study should be indicated, and clearly state the specific objectives of the study at the end of this section. Please ensure that any abbreviations and all symbols used in equations are fully defined. Approximate length: 500-1000 words.

 Materials and Methods (or Methods)

This section should describe the materials and methods used in sufficient detail to allow the study to be replicated. Please include details of ethical approval in this section. Methods of data analysis including the appropriate statistical analysis performed should be provided. Approximate length: 500-1000 words. Review Articles may not necessarily have a Materials and Methods section.


This section should first summarize all the results in text before referring to tables and figures for details. Please limit the number of tables and figures. It is essential to include statistical analyses or other indicators to enable assessment of the variance of replicates of the experiments. Data should not be repeated in figures and tables. Approximate length: 1000-1500 words. Review Articles may not necessarily have a Materials and Methods section.


The discussion section should summarize the main findings, interpret the findings, and compare with previous studies, as well as the contribution made to the field. Indicate unanswered questions/ provide direction for future research. This should be followed by a critique of the strengths and limitations of the research including any policy limitations. Approximate length: 1000 words. Review Articles may not necessarily have a Materials and Methods section.


A brief conclusions section should summarize the salient findings of the study based on the study objectives. Authors are strongly advised to emphasize the contribution made to the field by their study in this section. Approximate length: 200 words.


Review Articles may be structured along suitable segments of the review. However, an introduction and conclusion sections are required.


References should be typed single-spaced and numbered consecutively in the order in which they are cited in the text.

Names of all the authors should be indicated.

Arabic numerals (in superscript), e.g., 1, 1,3,5 or 1-4 should be used in citing references in the text.

Index Medicus Style of abbreviations should be used for journals cited.

For correct abbreviations visit

Unpublished work should not be included in the list of references.


Journal Articles

  1. Kola-Mustapha AT, Ubani-UkomaU, Ilomuanya MO, Nnamani O (2021) The COVID-19 response in Nigeria: Adequate protection of a fragile healthcare delivery system Nigerian  Journal of  Pharmacy 55 (1): 13-19

  1. Ayogu EE, Aluh DO and Igboeli NU (2021) Self-medication with antibiotics and anti-malarial drugs among rural dwellers in Enugu State, Nigeria Nigerian Journal of Pharmacy 55 (1): 6-12

  1. Izam YY and Aguiyi JC (2021) Effects of Carissa Edulisleaf extract on haematological Parameters of CCL4 induced albino rats. Nigerian Journal of Pharmacy 55 (1): 20-25


Meheus AZ (1984). Practical approaches in developing nations. In: Holmes KK, Mardh PA, Sparling PF, Wiesner PF, (eds). Sexually transmitted diseases. 1st edn. New York: McGraw-Hill, 998–1008 .

Online or website references

CDC/WHO 2005: HIV Rapid Testing training package CDC (WHO) training. Accessed September 20, 2016



These should be numbered with Arabic numerals. Each table should be typed using a table format (i.e., each variable must be typed into a separate cell in the table) with only horizontal lines above and below the table column headers and at the bottom of the table (using 1 pt for the top and bottom lines and ½ pt for any middle line). No vertical lines should be included in any table. Each table MUST not exceed 6.5 x inches (16.5 x 17.8 cm, width x height) and MUST be inserted at the appropriate position in the text just below where it was referred to the first time. The title should be typed at the top of the table in the sentence case format, i.e., only the first name should be in capital letters; names should also be in capital letters, as appropriate. Any legend should be typed at the top and bottom of the table in italics.


Figures should be professionally drawn electronically and inserted in the appropriate position where it was first cited within the text. If photographs of patients are used, either the subjects are not identifiable, or their pictures must be accompanied by a written permission to use the images. Photographs must be clear and sharp. Labels of figure MUST be in text form at the bottom and MUST not form part of the image.


It is a condition of publication that authors grant the Pharmaceutical Society of Nigeria the exclusive license to publish all articles, including abstracts. Authors retain copyright of their work, which means they may re-use their work for non-commercial purposes without asking permission of the publisher. Authors are themselves responsible for obtaining permission to reproduce copyright material from other sources.

 Ethical Matters

Authors using experimental animals and human subjects in their investigation must seek approval from the appropriate Ethical Committee in accordance with “Principles of Laboratory Animal Care” (NIH publication no. 85-23, revised 1985) and/or the Declaration of Helsinki promulgated in 1964 as amended in 1996. The Methods section must include a statement to prove that the investigation was approved and that informed consent was obtained.

 Galley Proofs

Unless indicated otherwise, galley proofs are sent to the email address given for corresponding author. It is the responsibility of the corresponding author to ensure that the galley proofs are returned without delay.























Editorial Board


The Nigerian Journal of Pharmacy (PSNNJP) is a peer-reviewed, open access journal which publishes original research articles, review articles and case studies on all aspects of pharmaceutical sciences and technologies, pharmacy practice and related clinical aspects, and pharmacy education. The journal publishes articles covering developments in drug absorption and metabolism, pharmacokinetics and dynamics, drug delivery systems, drug targeting and nanotechnology. It also covers development of new systems, methods, Clinical Pharmacy and techniques in pharmacy education and practice. PSNNJP provides a research, development and evaluation forum for communication between academic teachers, researchers and practitioners in professional and pharmacy education, with an emphasis on new and established teaching and learning methods, new curriculum and syllabus directions, educational outcomes, guidance on structuring courses and assessing achievement, and workforce development with a view to an all inclusive and intertwined view of Pharmacy from the perspective of the Industry, Hospital (Clinical and Administration), Community and policy makers.

In addition we are Currently working towards being listed in AJOL, EBSCO, and indexed in the Emerging Sources Citation Index (ESCI – Web of Science).

The Peer Review Process

The Nigerian Journal of Pharmacy has adopted a double-blind peer review process – the identities of the Authors and Reviewers are kept from being known to each other. A step-by-step checklist is provided for Authors, Reviewers and Editors to ensure this (see Ensuring a Blind Review).

Peer Review Process: Once a submission is received, the assigned Editor will select appropriate Reviewers based on their expertise and proven ability to critique. The peer reviews received will assist the Editor in determining the validity, significance and originality of the work submitted. Reviewers will also provide comment on manuscript content for scientific value, check for adherence to general scientific practice as well as Nigerian Journal of Pharmacy specific guidelines. The Peer Review process will look closely at methodology and the data validity, and consider the ethical approach. Reviewers are encouraged to provide suggestions for improvement and recommend to Editors if manuscripts should be accepted, accepted with revisions, or rejected.

Please note that an invitation for Authors to submit a revised version is not a guarantee of acceptance. Ultimately, the final decision lies with the Editor assigned to each submission. An Editor can reject any article at any time before publication, including after acceptance if concerns arise about the integrity of the work.

As part of their agreement with Nigerian Journal of Pharmacy, Reviewers will keep manuscripts and associated material strictly confidential, and will not appropriate Authors’ ideas before the manuscript is published. Once a review has been completed, Reviewers will be directed and expected to permanently delete/destroy any retained copies of manuscripts they hold.

Timeliness: Reviewers are expected to respond promptly to requests to review and to submit reviews within the time agreed. Reviewers are also required to declare their conflicts of interest and recuse themselves from the Peer Review process if a conflict exists. Editors will do their utmost to ensure timely processing of manuscripts. Authors will be notified on any unusual delays in publication of manuscripts via email. Authors will ne notified as soon as possible if a manuscript is going to be rejected, either by the Journal Manager or Editorial Team. 


Pharm. (Dr.) Margaret Ilomuanya 

Department of Pharmaceutics and Pharmaceutical Technology Faculty of Pharmacy University of Lagos, Nigeria 

Editorial Board

  1.        Pharm (Prof.) Falodun Abiodun (ChairmanEditorial Board)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Benin, Benin City, Edo, Nigeria

  1. 2. Pharm Michael Odeyemi
  2. 3. Pharm (Dr.) Solomon Nwafaru
  3. 4. Pharm Ole Joseph  

Department of Clinical Pharmacy, University of Ilorin, Kwara, Nigeria

  1. 5. Pharm (Prof.) Noel Wannang

Department of Pharmacology and Toxicology, University of Jos, Plateau, Nigeria; West African Postgraduate College of Pharmacists

  1. 6. Pharm Dr. Chukwuemeka Azubuike

Department of Pharmaceutics and Pharmaceutical Technology Faculty of Pharmacy University of Lagos, Nigeria 

  1. Pharm. (Prof.) Petra Nnamani

Department of Pharmaceutics, University of Nigeria Nsukka, Enugu Nigeria


A minimum of two issues will be published annually, No. 1 (MARCH/APRIL ISSUE); No. 2 (SEPTEMBER/OCTOBER ISSUE). As possible three issues will be used to give one edition per quarter.

Manuscript Submission

The complete manuscript should be sent as an e-mail attachment to: with the journal name and “Article Submission” in the subject line. A cover letter should accompany the submission and should be addressed to:

The Editor-in-Chief

Nigerian Journal of Pharmacy

Pharmacy House, 32, Faramobi Ajike, Street,

Anthony Village, Lagos, Nigeria

P.O Box 531, Mushin Lagos, Nigeria


Phone: +2348023091623

See more information on the Instructions to Authors page.

The Nigerian Journal of Pharmacy is a publication of the Pharmaceutical Society of Nigeria. The Editor-in-Chief of the Nigerian Journal of Pharmacy is an elected officer of PSN.



Pharm. (Prof). Cyril O. Usifoh, FPSN,FPCPHARM,FNAPHARM.


Pharm. Ibrahim H. Binji FPSN
Deputy President North


Pharm. (Dr) Egbuna C Udeorah,FPSN
Deputy President South


Pharm. Olugbenga A. Falabi, FPSN
National Secretary.


Pharm. Gafar 'Lanre Madehin, FPSN
National Treasurer


Pharm. (Dr) Murtala Isa Umar.
National Financial Sec.


Pharm. (Dr) Felix Ndiukwu, MAW
National Publicity Sec.


Pharm. Ikenna C.  Mbata, MAW, FIMC
Assistant National Secretary


Pharm. (Dr.) Margaret Ilomuanya  


Pharm Martins Oyewole FPSN
Internal Auditor


Pharm. (Dr) Obianuju Onwuatuegwu, FPSN,FPCPHARM
Unofficial member


Pharm. Dr. Kingsley Chiedu Amibor FPSN, FPCPharm
Unofficial Member

Pharm. Mazi Sam I. Ohuabunwa,


Immediate Past President


The Council of PSN is made up of the National Executive Committee, Chairman and Secretaries of all State Branches of PSN, Deans of all Faculties of Pharmacy in Nigeria, Directors of Pharmaceutical Services in all states of the Federation, Chairmen of Technical and Interest Groups of PSN, Registrar, Pharmacists Council of Nigeria and other specified Representatives.

The Technical and Interest Groups of PSN are:

Association of Community Pharmacists of Nigeria (ACPN)

Association of Hospital and Administrative Pharmacists of Nigeria (AHAPN)

Association of Industrial Pharmacists of Nigeria (NAIP)

Nigeria Association of Pharmacists in Academia (NAPA)

Association of Lady Pharmacists (ALPS)

PSN is directly responsible for the nurturing and development of the Pharmaceutical Association of Nigerian Students (PANS) and the PSN Young Pharmacists Group (PSN-YPG)